The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity

Cellular Immunology

Volumn 272, Issue 1, 2011, Pages 45-52

  Amir, Jamie ^a   Waite, Matthew ^a   Tobler, Jeffrey ^a   Catalfamo, Dana L ^a   Koutouzis, Theofilos ^a   Katz, Joseph ^a   Wallet, Shannon M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Lipopolysaccharide; Microbial translocation; N carboxyl (methyl lysine); Oral epithelial cells; Periodontal disease; Receptor for advanced glycated end products; Toll like receptor 4; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLUCOSE; HEMOGLOBIN A1C; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL INFILTRATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; DIABETES MELLITUS, TYPE 2; EPITHELIAL CELLS; FEMALE; HUMANS; HYPERGLYCEMIA; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATION; LIGANDS; MALE; MIDDLE AGED; MOUTH; PRIMARY CELL CULTURE; RECEPTOR CROSS-TALK; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 80455160201     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.09.008     Document Type: Article

References (47)

1. Mealey B.L., Oates T.W. Diabetes mellitus and periodontal diseases. J Periodontol 2006, 77:1289-1303.
2. Santos Tunes R., Foss-Freitas M.C., Nogueira-Filho Gda R. Impact of periodontitis on the diabetes-related inflammatory status. J Can Dent Assoc 2010, 76:a35.
3. Loe H. Periodontal disease the sixth complication of diabetes mellitus. Diabetes Care 1993, 16:329-334.
4. Taylor G.W. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 2001, 6:99-112.
5. Madianos P.N., Bobetsis Y.A., Kinane D.F. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingiva. J Clin Periodontol 2005, 32(Suppl. 6):57-71.
6. Page R.C., Kornman K.S. The pathogenesis of human periodontitis: an introduction. Periodontol 2000 1997, 14:9-11.
7. Gottsegen R. Diabetes and periodontal disease. J Periodontol 1991, 62:161-163.
8. Khader Y.S., Dauod A.S., El-Qaderi S.S., Alkafajei A., Batayha W.Q. Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J Diabetes Complications 2006, 20:59-68.
9. Grossi S.G., Genco R.J. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol 1998, 3:51-61.
10. Taylor G.W., Burt B.A., Becker M.P., Genco R.J., Shlossman M., Knowler W.C., Pettitt D.J. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996, 67:1085-1093.
11. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
12. Kimbrell D.A., Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet 2001, 2:256-267.
13. Medzhitov R., Janeway C. Innate immunity. N Engl J Med 2000, 343:338-344.
14. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J Leukoc Biol 2010, 87:989-999.
15. Medzhitov R., Janeway C. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000, 173:89-97.
16. Lin L. RAGE on the Toll Road?. Cell Mol Immunol 2006, 3:351-358.
17. Mahanonda R., Pichyangkul S. Toll-like receptors and their role in periodontal health and disease. Periodontol 2007, 2000(43):41-55.
18. Katz J., Wallet S., Cha S. Periodontal disease, the oral-systemic connection: " is it all the RAGE?" Quintessence Int 2010, 41:229-237.
19. Brentano F., Schorr O., Gay R.E., Gay S., Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 2005, 52:2656-2665.
20. Lucas M., Stuart L.M., Savill J., Lacy-Hulbert A. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol 2003, 171:2610-2615.
21. Mullick A.E., Tobias P.S., Curtiss L.K. Toll-like receptors and atherosclerosis: key contributors in disease and health?. Immunol Res 2006, 34:193-209.
22. Sugawara Y., Uehara A., Fujimoto Y., Kusumoto S., Fukase K., Shibata K., Sugawara S., Sasano T., Takada H. Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J Dent Res 2006, 85:524-529.
23. Ford P.J., Gamonal J., Seymour G.J. Immunological differences and similarities between chronic periodontitis and aggressive periodontitis. Periodontol 2010, 2000(53):111-123.
24. Weinberg A., Krisanaprakornkit S., Dale B.A. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 1998, 9:399-414.
25. Diamond D.L., Kimball J.R., Krisanaprakornkit S., Ganz T., Dale B.A. Detection of beta-defensins secreted by human oral epithelial cells. J Immunol Methods 2001, 256:65-76.
26. Dale B.A., Kimball J.R., Krisanaprakornkit S., Roberts F., Robinovitch M., O'Neal R., Valore E.V., Ganz T., Anderson G.M., Weinberg A. Localized antimicrobial peptide expression in human gingiva. J Periodontal Res 2001, 36:285-294.
27. Kollisch G., Kalali B.N., Voelcker V., Wallich R., Behrendt H., Ring J., Bauer S., Jakob T., Mempel M., Ollert M. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005, 114:531-541.
28. McCormick T.S., Weinberg A. Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2010, 2000(54):195-206.
29. Lamont R.J., Chan A., Belton C.M., Izutsu K.T., Vasel D., Weinberg A. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 1995, 63:3878-3885.
30. Geerts S.O., Nys M., De M.P., Charpentier J., Albert A., Legrand V., Rompen E.H. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol 2002, 73:73-78.
31. Lalla E., Lamster I.B., Drury S., Fu C., Schmidt A.M. Hyperglycemia, glycoxidation, receptor for advanced glycation endproducts potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis. Periodontol 2000 2000, 23:50-62.
32. 1999 International International Workshop for a Classification of Periodontal Diseases and Conditions. Papers. Oak Brook, Illinois, October 30-November 2, 1999. Ann Periodontol 4(i) (1999) 1-112.
33. Vaarala O., Atkinson M.A., Neu J. The " perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008, 57:2555-2562.
34. Bucciarelli L.G., Wendt T., Rong L., Lalla E., Hofmann M.A., Goova M.T., Taguchi A., Yan S.F., Yan S.D., Stern D.M., Schmidt A.M. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 2002, 59:1117-1128.
35. Hattori Y., Hattori S., Sato N., Kasai K. High-glucose-induced nuclear factor kappaB activation in vascular smooth muscle cells. Cardiovasc Res 2000, 46:188-197.
36. Inoguchi T., Xia P., Kunisaki M., Higashi S., Feener E.P., King G.L. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol 1994, 267:E369-E379.
37. Ishii H., Jirousek M.R., Koya D., Takagi C., Xia P., Clermont A., Bursell S.E., Kern T.S., Ballas L.M., Heath W.F., Stramm L.E., Feener E.P., King G.L. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996, 272:728-731.
38. Xia C.Q., Peng R., Annamalai M., Clare-Salzler M.J. Dendritic cells post-maturation are reprogrammed with heightened IFN-gamma and IL-10. Biochem Biophys Res Commun 2007, 352:960-965.
39. Yerneni K.K., Bai W., Khan B.V., Medford R.M., Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 1999, 48:855-864.
40. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321.
41. Cerami A., Vlassara H., Brownlee M. Role of advanced glycosylation products in complications of diabetes. Diabetes Care 1988, 11(Suppl. 1):73-79.
42. Scannapieco F.A., Dasanayake A.P., Chhun N. Does periodontal therapy reduce the risk for systemic diseases?. Dent Clin North Am 2010, 54:163-181.
43. Mealey B.L., Rose L.F. Diabetes mellitus and inflammatory periodontal diseases. Curr Opin Endocrinol Diabetes Obes 2008, 15:135-141.
44. Wada K., Kamisaki Y. Molecular dissection of Porphyromonas gingivalis-related arteriosclerosis: a novel mechanism of vascular disease. Periodontol 2000, 54:222-234.
45. Forner L., Larsen T., Kilian M., Holmstrup P. Incidence of bacteremia after chewing tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006, 33:401-407.
46. Kinane D.F., Riggio M.P., Walker K.F., MacKenzie D., Shearer B. Bacteraemia following periodontal procedures. J Clin Periodontol 2005, 32:708-713.
47. Lalla E., Lamster I.B., Feit M., Huang L., Spessot A., Qu W., Kislinger T., Lu Y., Stern D.M., Schmidt A.M. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 2000, 105:1117-1124.